Xencor, Inc. (XNCR)
NASDAQ: XNCR · IEX Real-Time Price · USD
18.26
-0.76 (-4.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Xencor Revenue

Xencor had revenue of $162.18M in the twelve months ending March 31, 2024, with 65.41% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $12.81M, a -32.47% decrease year-over-year. In the year 2023, Xencor had annual revenue of $168.34M with 2.28% growth.

Revenue (ttm)
$162.18M
Revenue Growth
+65.41%
P/S Ratio
6.94
Revenue / Employee
$579,218
Employees
280
Market Cap
1.13B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023168.34M3.76M2.28%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020122.69M-34.01M-21.70%
Dec 31, 2019156.70M116.10M285.93%
Dec 31, 201840.60M-5.55M-12.02%
Dec 31, 201746.15M-62.87M-57.67%
Dec 31, 2016109.02M81.26M292.70%
Dec 31, 201527.76M18.24M191.62%
Dec 31, 20149.52M-652.00K-6.41%
Dec 31, 201310.17M648.00K6.80%
Dec 31, 20129.52M2.68M39.06%
Dec 31, 20116.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AtriCure 414.60M
Prothena Corporation 89.25M
Immatics 80.95M
Vir Biotechnology 79.60M
4D Molecular Therapeutics 20.45M
Spyre Therapeutics 688.00K
Revenue Rankings